October 22, 2007 — Pitrakinra, an inhibitor of interleukins-4 and -13* in the lung, may noticeably reduce asthma symptoms and improve response to allergen challenge, according to the results of a ...
Asthma is one of the most common lung diseases in the world, affecting some 262 million people worldwide and causing more than 450,000 deaths annually, per the World Health Organization. While ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback